BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Trevi Therapeutics
TRVI
$2.59B
| $9.34M | ﹤0.01% |
3,135,115
+759,406
| +32% | +$2.11M |
|
3352
Townsquare Media
TSQ
$116M
| $9.3M | ﹤0.01% |
848,578
+192,423
| +29% | +$2.22M |
|
|
GBIO
3353
DELISTED
Generation Bio
GBIO
| $9.29M | ﹤0.01% |
329,425
+24,540
| +8% | +$797K |
|
3354
eGain
EGAN
$200M
| $9.28M | ﹤0.01% |
1,471,293
-68,554
| -4% | -$425K |
|
|
RSVR
3355
Reservoir Media
RSVR
$655M
| $9.26M | ﹤0.01% |
1,171,971
+3,630
| +0.3% | +$28.9K |
|
3356
Virginia National Bankshares
VABK
$253M
| $9.24M | ﹤0.01% |
281,622
+2,627
| +0.9% | +$76.5K |
|
3357
Pyxis Oncology
PYXS
$196M
| $9.22M | ﹤0.01% |
2,785,895
+2,464,230
| +766% | +$10.4M |
|
3358
Achieve Life Sciences
ACHV
$651M
| $9.2M | ﹤0.01% |
1,956,510
+1,904,079
| +3,632% | +$9.17M |
|
|
NOAH
3359
Noah Holdings
NOAH
$582M
| $9.17M | ﹤0.01% |
950,519
-54,571
| -5% | -$673K |
|
3360
GrowGeneration
GRWG
$88.9M
| $9.12M | ﹤0.01% |
4,243,618
-104,950
| -2% | -$266K |
|
3361
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$112M
| $9.09M | ﹤0.01% |
326,093
-8,809
| -3% | -$244K |
|
3362
Nathan's Famous
NATH
$401M
| $9.06M | ﹤0.01% |
133,626
-7,226
| -5% | -$489K |
|
3363
Kodiak Sciences
KOD
$2.56B
| $9.04M | ﹤0.01% |
3,846,827
-11,794
| -0.3% | -$40K |
|
3364
ProKidney
PROK
$324M
| $8.99M | ﹤0.01% |
3,656,276
+924,617
| +34% | +$2.48M |
|
3365
Skye Bioscience
SKYE
$20.6M
| $8.96M | ﹤0.01% |
+1,118,767
| New | +$13.3M |
|
3366
Fresenius Medical Care
FMS
$12.6B
| $8.96M | ﹤0.01% |
469,403
+23,774
| +5% | +$485K |
|
3367
Nautilus Biotechnolgy
NAUT
$127M
| $8.96M | ﹤0.01% |
3,827,577
+95,773
| +3% | +$250K |
|
3368
Foghorn Therapeutics
FHTX
$282M
| $8.89M | ﹤0.01% |
1,546,069
+230,698
| +18% | +$1.37M |
|
3369
Monte Rosa Therapeutics
GLUE
$1.35B
| $8.83M | ﹤0.01% |
2,360,093
+53,084
| +2% | +$271K |
|
3370
Investar Holding Corp
ISTR
$420M
| $8.81M | ﹤0.01% |
572,004
+422,272
| +282% | +$6.68M |
|
3371
RUM Group Inc
RUM
$1.76B
| $8.81M | ﹤0.01% |
1,586,631
+83,868
| +6% | +$540K |
|
3372
Information Services Group
III
$209M
| $8.74M | ﹤0.01% |
2,974,478
+207,320
| +7% | +$697K |
|
3373
Southern California Bancorp
BCAL
$696M
| $8.74M | ﹤0.01% |
649,205
+485,755
| +297% | +$6.75M |
|
3374
ThredUp
TDUP
$818M
| $8.74M | ﹤0.01% |
5,140,469
+392,509
| +8% | +$715K |
|
3375
iShares International Select Dividend ETF
IDV
$8.47B
| $8.72M | ﹤0.01% |
315,218
-494,834
| -61% | -$14.1M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,441 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.